Design and test of preference for a new prescription medication label

Zargarzadeh, Amir H.; Law, Anandi V.

doi:10.1007/s11096-011-9488-z

Cited by 23 publications

(17 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, a number of earlier studies support the acceptability and preference of the many patient-centered modifications under study. [34][35][36] The majority of patients did not receive a benefit from the PCL, but in no instance did we find that it performed worse than standard labeling. As the intervention involved subtle modifications to pharmacy-generated labeling that could be readily put into practice, set to scale, even small increases in proper use and adherence among subgroups of consumers might yield a cost benefit.…”

Section: Discussionmentioning

confidence: 99%

A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence

et al. 2016

View full text Add to dashboard Cite

BACKGROUND: Patient misunderstanding of prescription drug label instructions is a common cause of unintentional misuse of medication and adverse health outcomes. Those with limited literacy and English proficiency are at greater risk. OBJECTIVE: To test the effectiveness of a patientcentered drug label strategy, including a Universal Medication Schedule (UMS), to improve proper regimen use and adherence compared to a current standard. DESIGN: Two-arm, multi-site patient-randomized pragmatic trial. PARTICIPANTS: English-and Spanish-speaking patients from eight community health centers in northern Virginia who received prescriptions from a central-fill pharmacy and who were 1) ≥30 years of age, 2) diagnosed with type 2 diabetes and/or hypertension, and 3) taking ≥2 oral medications. INTERVENTION: A patient-centered label (PCL) strategy that incorporated evidence-based practices for format and content, including prioritized information, larger font size, and increased white space. Most notably, instructions were conveyed with the UMS, which uses standard intervals for expressing when to take medicine (morning, noon, evening, bedtime). MAIN MEASURES: Demonstrated proper use of a multidrug regimen; medication adherence measured by selfreport and pill count at 3 and 9 months. KEY RESULTS: A total of 845 patients participated in the study (85.6 % cooperation rate). Patients receiving the PCL demonstrated slightly better proper use of their drug regimens at first exposure (76.9 % vs. 70.1 %, p = 0.06) and at 9 months (85.9 % vs. 77.4 %, p = 0.03). The effect of the PCL was significant for English-speaking patients (OR 2.21, 95 % CI 1.13-4.31) but not for Spanish speakers (OR 1.19, 95 % CI 0.63-2.24). Overall, the intervention did not improve medication adherence. However, significant benefits from the PCL were found among patients with limited literacy (OR 5.08,) and for those with medications to be taken ≥2 times a day (OR 2.77, 95 % CI 1.17-6.53). CONCLUSIONS:A simple modification to pharmacygenerated labeling, with minimal investment required, can offer modest improvements to regimen use and adherence, mostly among patients with limited literacy and more complex regimens. Trial Registration (ClinicalTrials.gov): NCT00973180, NCT01200849

show abstract

Section: Discussionmentioning

confidence: 99%

A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Presented with a choice, most patients prefer instructional leaflets and prescription labels that include indications to those that don't include indications. 4 Knowledge of the indication can also empower patients to question the necessity of a medication.…”

Section: Incorporating Indications Into Medication Ordering -Time To mentioning

confidence: 99%

Incorporating Indications into Medication Ordering — Time to Enter the Age of Reason

2016

View full text Add to dashboard Cite

“…Previous qualitative studies, which have focused on the content and design of the dispensed medicine label, have found that 28% to 91% of patients were in favour of documenting the indication on the dispensed medicine label [ 7 – 13 ]. Additionally, two literature reviews on best label practice, comprising the results of 135 individual studies, found that consumers want the indication documented on the dispensed medicines labels to better understand/remember what the medications are used for [ 14 , 15 ].…”

Section: Introductionmentioning

confidence: 99%

What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: A qualitative study

Garada

McLachlan

Schiff

et al. 2017

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundDocumenting the indication on prescriptions and dispensed medicines labels is not standard practice in Australia. However, previous studies that have focused on the content and design of dispensed medicines labels, have suggested including the indication as a safety measure. The aim of this study was to investigate the perspectives of Australian consumers, pharmacists and prescribers on documenting the indication on prescriptions and dispensed medicines labels.MethodsSemi-structured interviews were conducted and mock-up of dispensed medicines labels were designed for participants. Consumers (n = 19) and pharmacists (n = 7) were recruited by convenience sample at community pharmacies in Sydney (Australia) and prescribers (n = 8), including two medical students, were recruited through snowballing.ResultsThirty-four participants were interviewed. Most participants agreed that documenting the indication would be beneficial especially for patients who are forgetful or take multiple medications. Participants also believed it would improve consumers’ medication understanding and adherence. Prescribers and pharmacists believed it could help reduce prescribing and dispensing errors by matching the drug/dosage to the correct indication. Prescribers refrained from documenting the indication to protect patients’ privacy; however, most patients did not consider documenting the indication as a breach of privacy. Prescribers raised concerns about the extra time to include indications on prescriptions and best language to document indications, using plain language as opposed to medical terminology.ConclusionsAll interviewed stakeholders identified numerous benefits of documenting the indication on prescriptions and dispensed medicines labels. Whether these potential benefits can be realized remains unknown and addressing prescribers’ concern regarding the time involved in documenting the indication on prescriptions remains a challenge for vendors of electronic medication management systems.Electronic supplementary materialThe online version of this article (10.1186/s12913-017-2704-3) contains supplementary material, which is available to authorized users.

show abstract

Design and test of preference for a new prescription medication label

Abstract: New prescription labels were favored over existing labels by all stakeholders, for content, convenience and cosmetic appearance. The results may help in making labels more user-friendly and addressing problem areas in labels.

Cited by 23 publications

References 20 publications

A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence

A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence

Incorporating Indications into Medication Ordering — Time to Enter the Age of Reason

What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: A qualitative study

Contact Info

Product

Resources

About